FDA approves expanded use of Humira

Abbott Laboratories has won expanded approval of its rheumatoid arthritis drug Humira. Humira is now approved for psoriatic arthritis and as a front-line RA therapy. The drug targets a misdirected immune response in which healthy tissue is attacked, inducing skin inflammation, swelling and pain.

- read this AP article for more

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.